Zinzino's July Numbers Show What Consistent Global Growth Looks Like
Zinzino reported July revenue of $33.2 million, up 20 percent year over year, with its Faun Pharma line growing 14 percent. Nearly every region the company operates in showed growth compared to the second quarter, including Central Europe, South and West Europe, North America, South America, Asia Pacific, and Africa. Only the Nordics, East Europe, and the Baltics lagged behind.
What stands out here is the breadth. A single hot market carrying a whole company's growth is common in direct selling and it is fragile, because one regulatory change or one competitor move can wipe it out fast. Growth spread across a dozen countries at once is a much harder thing to build and a much better sign of a business model that travels well.
Running that many markets well at the same time is an operations problem as much as a sales one. Every country has its own compliance rules, payout timing, and support expectations, and keeping all of that consistent without slowing anyone down is where a lot of fast growing companies start to strain. Automating the parts of compensation, onboarding, and distributor communication that repeat across markets is usually what lets a company keep adding countries without adding proportional headcount.
If your company is scaling into new markets and starting to feel that strain, it is worth talking through your current setup with Plondo at https://plondo.com/contact.

